Investor Readiness Scorecard
Self-assess across 20 criteria covering technology de-risking, commercial traction, regulatory readiness, team completeness, and financial planning.
Core process demonstrated at bench scale with reproducible results
You can produce your target ingredient/product consistently across multiple runs with documented process parameters.
Preliminary TEA completed — COGS within 3x of target price
You have a credible estimate of your cost of goods at commercial scale, and it is within the range of commercial viability.
IP strategy defined and initial protection in place
You have made a deliberate decision about patent vs. trade secret, and have taken initial steps to protect your core innovation.
Scale-up risks identified and mitigation plan documented
You have a clear understanding of the technical risks of scaling up and a plan for addressing them.
Customer discovery completed — 10+ interviews with target buyers
You have spoken directly with at least 10 potential customers and can articulate their specific pain points and purchasing criteria.
At least one paid pilot or LOI signed with a strategic partner
A real organisation has committed, in writing, to testing or purchasing your product.
Clear revenue model with validated pricing
You know what you will charge, who will pay it, and why they will pay it — supported by evidence from customer conversations.
Competitive landscape mapped with clear differentiation articulated
You know who your competitors are, what they offer, and why your solution is meaningfully better for your target customer.
Regulatory pathway identified and timeline documented
You know exactly which regulatory approvals you need, in which markets, and have a realistic timeline for achieving them.
Regulatory costs budgeted in fundraise
Your capital raise includes a specific allocation for regulatory costs, based on a realistic estimate.
Pre-submission dialogue initiated with relevant authority
You have had at least one conversation with the relevant regulatory body (EFSA, FDA, FSA) about your product.
Label and marketing claims reviewed for compliance
A qualified regulatory consultant has reviewed your labels and marketing materials for compliance.
Core technical capability in-house or contracted
The scientific expertise required to execute your R&D roadmap is available to the company.
Commercial leadership identified (hire or advisor)
Someone with credible commercial experience is actively involved in the business.
Advisory board includes at least one industry operator
Your advisory board includes someone who has built and scaled a food ingredient or product company.
Capability gaps documented and hiring plan in place
You have a clear view of what capabilities you are missing and a plan for addressing them.
18-month financial model built and stress-tested
You have a bottom-up financial model covering the next 18 months, with revenue, cost, and cash flow projections.
Capital requirements linked to specific milestones
Every euro of your fundraise is linked to a specific technical or commercial milestone.
Use of funds clearly articulated
You can explain, in one slide, exactly how you will spend the capital you are raising and what it will achieve.
Path to next funding round defined
You know what milestones you need to achieve to raise your next round, and at what valuation.
0%
Early R&D Stage
Core process demonstrated at bench scale with reproducible results
Preliminary TEA completed — COGS within 3x of target price
IP strategy defined and initial protection in place